In AD brain, HMGB1 is significantly increased and co-localizes with amyloid plaques (Xu et al., 2024), and inhibits microglial Aβ42 uptake, increasing Aβ42 accumulation and amyloidogenicity (Takata et al., 2003). Here, HMGB1 is linked to Alzheimer disease.